---
title: "Pre-market hot trades in US stocks: Haoxin pre-market down 20.30%; Strata Skin Sciences pre-market down 19.42%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/276107971.md"
description: "Haoxin pre-market down 20.30%; Strata Skin Sciences pre-market down 19.42%; Leifras pre-market up 49.59%; TG-17 pre-market up 47.60%; Ernexa Therapeutics pre-market up 39.35%"
datetime: "2026-02-17T09:12:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276107971.md)
  - [en](https://longbridge.com/en/news/276107971.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276107971.md)
---

# Pre-market hot trades in US stocks: Haoxin pre-market down 20.30%; Strata Skin Sciences pre-market down 19.42%

**Pre-market Hot Trades in US Stocks**

Haoxin, down 20.30% in pre-market trading, has no significant news recently. The trading is active, with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Strata Skin Sciences is down 19.42% in pre-market trading. Based on recent key news:

1.  On February 16, Martin Hunt, the non-executive chairman of Strata Skin Sciences, took on an executive role as the company is searching for temporary and permanent CEO replacements. This news led to a significant pre-market drop of about 19.42% in the stock price.
    
2.  On February 16, former CEO Ashman raised market concerns by not responding to a LinkedIn inquiry, further exacerbating the decline in stock price.
    
3.  On February 16, the company's stock price plummeted about 45% in early trading, reflecting market unease over management changes. Recent management changes have triggered market volatility.
    

**Top Gainers in Pre-market US Stocks**

Leifras, up 49.59% in pre-market trading, has no significant news recently. The trading is active, with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

TG-17, up 47.60% in pre-market trading, has no significant news recently. The trading is active, with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Ernexa is up 39.35% in pre-market trading. There is no significant news recently; the trading is active, with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no\_news

### Related Stocks

- [HXHX.US](https://longbridge.com/en/quote/HXHX.US.md)
- [SSKN.US](https://longbridge.com/en/quote/SSKN.US.md)

## Related News & Research

- [IMF's Georgieva: March was a tough month for economy, April may be much tougher](https://longbridge.com/en/news/282864934.md)
- [Beyond SPY: Active ETFs Poised To Lead Next Phase Of $25 Trillion Industry Boom](https://longbridge.com/en/news/282571072.md)
- [Imf's Gourinchas Central Banks Don't Need To Step On The Brakes Right Away](https://longbridge.com/en/news/282708859.md)
- [Hidden costs of war: $8 trillion spent, trillions more in debt & long-term impact](https://longbridge.com/en/news/282735241.md)
- [Here's How Much $100 Invested In NextEra Energy 15 Years Ago Would Be Worth Today](https://longbridge.com/en/news/282403406.md)